Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Aufsatznummer139
FachzeitschriftMarine drugs
Jahrgang23
Ausgabenummer4
PublikationsstatusVeröffentlicht - 23 März 2025

Abstract

Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t 0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: -0.19 [-0.80-0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5-5.0) (EMM [95% CI]: -0.76 [-1.53-0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance. / Kerlikowsky, Felix; Bartsch, Madeline; Jonas, Wiebke et al.
in: Marine drugs, Jahrgang 23, Nr. 4, 139, 23.03.2025.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Kerlikowsky, Felix ; Bartsch, Madeline ; Jonas, Wiebke et al. / Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance. in: Marine drugs. 2025 ; Jahrgang 23, Nr. 4.
Download
@article{7bafb17b320e4ffab7b34a1c5ef14596,
title = "Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance",
abstract = "Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t 0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: -0.19 [-0.80-0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5-5.0) (EMM [95% CI]: -0.76 [-1.53-0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype. ",
keywords = "Humans, Insulin Resistance/physiology, Obesity/drug therapy, Female, Double-Blind Method, Male, Middle Aged, Homeostasis/drug effects, Blood Glucose/drug effects, Adult, Dietary Supplements, Life Style, Diabetes Mellitus, Type 2, Fatty Acids, Omega-3/administration & dosage, Animals, lifestyle intervention, calanus firmarchicus, dietary supplements, homeostatic model assessment of insulin resistance",
author = "Felix Kerlikowsky and Madeline Bartsch and Wiebke Jonas and Andreas Hahn and Schuchardt, {Jan Philipp}",
year = "2025",
month = mar,
day = "23",
doi = "10.3390/md23040139",
language = "English",
volume = "23",
journal = "Marine drugs",
issn = "1660-3397",
publisher = "Multidisciplinary Digital Publishing Institute",
number = "4",

}

Download

TY - JOUR

T1 - Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance

AU - Kerlikowsky, Felix

AU - Bartsch, Madeline

AU - Jonas, Wiebke

AU - Hahn, Andreas

AU - Schuchardt, Jan Philipp

PY - 2025/3/23

Y1 - 2025/3/23

N2 - Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t 0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: -0.19 [-0.80-0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5-5.0) (EMM [95% CI]: -0.76 [-1.53-0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.

AB - Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t 0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: -0.19 [-0.80-0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5-5.0) (EMM [95% CI]: -0.76 [-1.53-0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.

KW - Humans

KW - Insulin Resistance/physiology

KW - Obesity/drug therapy

KW - Female

KW - Double-Blind Method

KW - Male

KW - Middle Aged

KW - Homeostasis/drug effects

KW - Blood Glucose/drug effects

KW - Adult

KW - Dietary Supplements

KW - Life Style

KW - Diabetes Mellitus, Type 2

KW - Fatty Acids, Omega-3/administration & dosage

KW - Animals

KW - lifestyle intervention

KW - calanus firmarchicus

KW - dietary supplements

KW - homeostatic model assessment of insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=105003460969&partnerID=8YFLogxK

U2 - 10.3390/md23040139

DO - 10.3390/md23040139

M3 - Article

C2 - 40278260

VL - 23

JO - Marine drugs

JF - Marine drugs

SN - 1660-3397

IS - 4

M1 - 139

ER -

Von denselben Autoren